Thrombophilia in coronary artery disease: a double jeopardy

D Mohanty1, K Ghosh, A Khare

  • 1Institute of Immunohaematology (ICMR), Mumbai, India. mohanty@bom5.vsnl.net.in

Insights

Thrombophilia, an increased thrombosis risk, involves haemostasis disruption. Investigating thrombophilia in Indian young myocardial infarction patients is crucial due to rising cases and lack of conventional risk factors.

Area of Science:

  • Cardiology
  • Hematology
  • Genetics

Background:

  • Thrombophilia signifies an elevated risk of thrombosis, stemming from genetic or environmental haemostasis perturbations.
  • Coronary artery disease (CAD) pathogenesis involves atheroma development, leading to angina and myocardial infarction (MI).
  • Emerging research explores blood coagulation factors, natural anticoagulants, platelet antigens, homocysteine, and lipoprotein (a) in arterial thrombosis and CAD risk.

Purpose of the Study:

  • To investigate the role of thrombophilia in young Indian patients experiencing myocardial infarction (MI).
  • To address the rising incidence of MI in young Indians lacking traditional risk factors.
  • To evaluate the significance and cost-effectiveness of thrombophilia investigations in India.

Main Methods:

  • Review of existing literature on thrombophilia and its association with arterial thrombosis.
  • Analysis of studies on coagulation factors, natural anticoagulants, and other risk factors in CAD.
  • Consideration of clinical trial data on thrombophilia management.

Main Results:

  • Contradictory findings exist regarding the role of various factors in arterial thrombosis and CAD.
  • A notable increase in young MI patients in India is observed, often without conventional risk factors.
  • Limited studies on thrombophilia status among Indian populations highlight a knowledge gap.

Conclusions:

  • Thrombophilia is a significant consideration in unexplained MI, particularly in younger populations.
  • Cost-effective selection of thrombophilia investigations is paramount for developing countries like India.
  • Further research is needed to clarify the role of thrombophilia in the Indian context and guide management strategies.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...